SCHEMBL7301097

SCHEMBL7301097

CC(C)C(NC(=O)N(C)Cc1nccc2ccccc12)C(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 3/20 0.37
MAPT P10636 3/20 0.37
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
CCR3 P51677 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
BCL9 O00512 1/20 0.36
CTNNB1 P35222 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301102 1.00 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2GAAMAPTMMP1
SCHEMBL4680503 0.83 CA2 (0.51) ALDH1A1SMN1; SMN2GAAMAPTKDM4E
SCHEMBL4680500 0.83 CA2 (0.51) ALDH1A1SMN1; SMN2GAAMAPTKDM4E
SCHEMBL7334206 0.79 KMT2A (0.47) ALDH1A1SMN1; SMN2GAAKDM4EMEN1
SCHEMBL7304760 0.78 MAPT (0.47) ALDH1A1SMN1; SMN2GAAMAPTKDM4E
SCHEMBL7303865 0.78 GAA (0.41) ALDH1A1GAAMAPTKDM4ELMNA
SCHEMBL7303870 0.78 GAA (0.41) ALDH1A1GAAMAPTKDM4ELMNA
SCHEMBL7304768 0.78 MAPT (0.47) ALDH1A1SMN1; SMN2GAAMAPTKDM4E
SCHEMBL7307810 0.77 PKM (0.49) ALDH1A1SMN1; SMN2GAAMAPTMMP2
SCHEMBL7307803 0.77 PKM (0.49) ALDH1A1SMN1; SMN2GAAMAPTMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed